Home » Wen’s shares: It is expected that the cost will return to normal in the fourth quarter of this year, and some production indicators in the first half of the year will be close to the level before the epidemic.

Wen’s shares: It is expected that the cost will return to normal in the fourth quarter of this year, and some production indicators in the first half of the year will be close to the level before the epidemic.

by admin

Summary

[Wen’s shares: It is expected that costs will return to normal in the fourth quarter of this year. Some production indicators in the first half of this year are close to non-pre-pandemic levels.]Wen’s (300498) held a conference call yesterday and revealed that the company’s pig production in the first half of the year had a significant turning point, and some production indicators were close to non- Before the epidemic, production has improved overall. In general, there is no significant adjustment to the slaughter target for this year and next year, about 11-12 million heads this year, and about 18-20 million heads next year. The company’s existing production capacity can meet the development needs of this year and next, and there is no need for large-scale capital expenditures for the time being. In terms of cost, the current cost is a periodical abnormal fluctuation. The company suspended the outsourcing of piglets in May, and it is expected that the cost will return to normal in the fourth quarter of this year. (Securities Times)


  Wen’s shares(300498) A conference call held yesterday revealed that in the first half of the year, the company’s pig production had a significant turning point, and some production indicators were close to the pre-pest level, and production had improved in an all-round way. In general, there is no significant adjustment to the slaughter target for this year and next year, about 11-12 million heads this year, and about 18-20 million heads next year. The company’s existing production capacity can meet the development needs of this year and next, and there is no need for large-scale capital expenditures for the time being. In terms of cost, the current cost is a periodical abnormal fluctuation. The company suspended the outsourcing of piglets in May, and it is expected that the cost will return to normal in the fourth quarter of this year.

See also  Anxu Biological Performance Report: Net profit of 739 million yuan in 2021, a year-on-year increase of 13.82%_Oriental Fortune Network

(Source: Securities Times)

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy